HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mamoru Hyodo Selected Research

bis(3',5')-cyclic diguanylic acid

10/2015Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma.
6/2014A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy.
1/2014c-di-GMP enhances protective innate immunity in a murine model of pertussis.
9/2011STING is a direct innate immune sensor of cyclic di-GMP.
2/2011The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides.
7/2009c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
2/2009The Anaplasma phagocytophilum PleC histidine kinase and PleD diguanylate cyclase two-component system and role of cyclic Di-GMP in host cell infection.
8/2008c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.
10/2007Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.
2/2007Bacterial c-di-GMP is an immunostimulatory molecule.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mamoru Hyodo Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 04/2005
8Infections
03/2016 - 03/2005
7Bites and Stings (Sting)
08/2022 - 02/2011
4Body Weight (Weight, Body)
10/2013 - 10/2012
3Melanoma (Melanoma, Malignant)
08/2022 - 10/2015
3Neoplasm Metastasis (Metastasis)
08/2022 - 10/2015
3Obesity
03/2014 - 03/2013
2Reperfusion Injury
12/2015 - 09/2015
2Renal Cell Carcinoma (Grawitz Tumor)
08/2014 - 01/2012
2Bacterial Infections (Bacterial Infection)
02/2011 - 08/2008
2Staphylococcal Infections
07/2009 - 02/2007
2Persistent Infection
01/2009 - 03/2005
2Mastitis
08/2005 - 03/2005
1Dehydration (Water Stress)
09/2021
1Shock
01/2021
1Lymphoma (Lymphomas)
03/2016
1Metabolic Diseases (Metabolic Disease)
03/2014
1Type 2 Diabetes Mellitus (MODY)
03/2014
1Disease Progression
03/2014
1Overweight
03/2014
1Whooping Cough (Pertussis)
01/2014
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2013
1Anaplasmosis
02/2009
1Chronic Disease (Chronic Diseases)
01/2009
1Pneumococcal Infections
08/2008
1Communicable Diseases (Infectious Diseases)
08/2008
1Pneumonia (Pneumonitis)
10/2007
1Bacterial Pneumonia
10/2007
1Neuroblastoma
04/2005
1Colonic Neoplasms (Colon Cancer)
04/2005

Drug/Important Bio-Agent (IBA)

12bis(3',5')-cyclic diguanylic acidIBA
10/2015 - 03/2005
7LigandsIBA
01/2021 - 01/2012
7Small Interfering RNA (siRNA)IBA
03/2016 - 01/2012
6InterferonsIBA
08/2022 - 02/2011
6Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2009
4YSK05IBA
10/2015 - 06/2013
4Peptides (Polypeptides)IBA
10/2013 - 01/2012
3Lipid NanoparticlesIBA
08/2022 - 01/2021
3Liposomes (Liposome)IBA
10/2015 - 06/2014
3LipidsIBA
10/2015 - 06/2013
3Interferon Type IIBA
10/2015 - 02/2011
3Nucleotide AptamersIBA
08/2014 - 01/2012
3Phosphotransferases (Kinase)IBA
06/2014 - 01/2009
3DNA (Deoxyribonucleic Acid)IBA
05/2013 - 02/2011
3Vaccine AdjuvantsIBA
07/2009 - 10/2007
2Biomarkers (Surrogate Marker)IBA
08/2014 - 01/2012
2LeptinIBA
10/2013 - 03/2013
2NucleotidesIBA
09/2011 - 02/2011
2Immunologic Factors (Immunomodulators)IBA
08/2008 - 10/2007
2GpGpIBA
08/2005 - 04/2005
2Anti-Infective Agents (Microbicides)IBA
04/2005 - 03/2005
1allyl alcohol (allylic alcohol)IBA
09/2021
1Silicon Dioxide (Silica)FDA LinkGeneric
09/2021
1AcidsIBA
09/2021
1HydrogenIBA
09/2021
1pristane (pristan)IBA
09/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1SaltsIBA
01/2021
1CytokinesIBA
03/2016
1SphingosineIBA
12/2015
1Hyaluronic Acid (Hyaluronan)IBA
12/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2015
1coenzyme Q10 (CoQ10)IBA
09/2015
1APTIBA
08/2014
1Troponin T (Troponin T1)IBA
08/2014
1AntigensIBA
06/2014
1Adenosine Triphosphate (ATP)IBA
06/2014
1RNA Helicases (RNA Helicase)IBA
06/2014
1Blood Glucose (Blood Sugar)IBA
03/2014
1EnzymesIBA
03/2014
1AcyltransferasesIBA
03/2014
1Triglycerides (Triacylglycerol)IBA
03/2014
1MonoglyceridesIBA
03/2014
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2014
1ProhibitinsIBA
10/2013
1CKGGRAKDC-GG-D(KLAKLAK)2IBA
10/2013
1Messenger RNA (mRNA)IBA
06/2013
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2013
1cyclic guanosine monophosphate-adenosine monophosphateIBA
05/2013
1Anti-Obesity Agents (Antiobesity Drugs)IBA
03/2013
1Cytochromes c (Cytochrome c)IBA
03/2013
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
11/2012
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2012
1Nucleic AcidsIBA
09/2011
1RNA (Ribonucleic Acid)IBA
02/2011
1cyclic diadenosine phosphateIBA
02/2011
1Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA
02/2011
1diguanylate cyclaseIBA
02/2009
1Histidine KinaseIBA
02/2009
1N,N'- dipyridoxylethylenediamine- N,N'- diacetic acid (PLED)IBA
02/2009
1Virulence Factors (Pathogenicity Factors)IBA
01/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2005
1Epidermal Growth Factor (EGF)IBA
04/2005
1Acetylcholine (Acetylcholine Chloride)FDA Link
04/2005
1Anti-Bacterial Agents (Antibiotics)IBA
03/2005

Therapy/Procedure

7Therapeutics
08/2022 - 10/2013
5Immunotherapy
01/2022 - 06/2014
1Intravenous Administration
10/2015
1Injections
01/2014